Stockpolly
Search
Delisting risk
TRAW · NASDAQ · Biotechnology

Traws Pharma (TRAW)

Develops oral antivirals for influenza and COVID-19.

$0.5800
Pre-market+0.01 (+1.79%)
At close$0.5698(−3.42%)
Watchlist

In millions of USD, except per-share figures

In millionsQ4 FY20Dec 2020Q2 FY21Jun 2021Q4 FY21Dec 2021Q2 FY22Jun 2022Q4 FY22Dec 2022Q2 FY23Jun 2023Q4 FY23Dec 2023Q2 FY24Jun 2024Q4 FY24Dec 2024Q2 FY25Jun 2025Q4 FY25Dec 2025Q2 FY26Mar 2026
Revenue000000000300
Cost of revenue000000000000
Gross profit000000000300
1398811111059477
Research & development944477525255
454444533222
General & administrative452444533222
Operating income−13−9−8−8−11−11−10−5−9−1−7−7
001011100000
Other non-operating income000000000000
Income before tax−13−9−7−8−11−10−9−5−8−1−7−7
Net income from continuing operations−13−9−7−8−11−10−9−5−8−1−7−7
Net income−13−9−7−8−11−10−9−5−8−1−7−7
EPS, basic−$25.91−$14.77−$9.91−$9.74−$12.93−$11.95−$10.62−$5.92−$8.81−$0.11−$0.34−$0.53
EPS, diluted−$25.91−$14.77−$9.91−$9.74−$12.93−$11.95−$10.62−$5.92−$8.81−$0.11−$0.34−$0.53
Weighted average shares, basic0111111116811
Weighted average shares, diluted0111111116811
EBITDA−13−9−8−8−11−11−9−5−8−1−7−7
Depreciation & amortization000000000000
EBIT−13−9−8−8−11−11−9−5−8−1−7−7